NVHR Newsletters

Winter Update 2009-2010

NVHR logo black and red

 

NVHR.org Newsletter

FEBRUARY 2010

 

Steering Committee

Lorren Sandt, Chair

Jeff Caballero, Vice-Chair

Joan Block, Secretary

Dennis Simon, Treasurer

Bruce Burkett

Ryan Clary

Andrew Muir, MD

Michael Ninburg

Daniel Raymond

Chris Taylor

Deborah Wexler, MD

 

Staff

Martha Saly, Director

Mimi Schott, Admin Support

Rose Hessmiller,  Webmaster

 

 

 

  

Our Website 

 

Who Should Join NVHR?

 

Any organization committed to viral hepatitis prevention, care, advocacy, and education

 

 

Eligible to be a Voting Member:

 

 ·    Community-based organizations

 · Clinics and health care  agencies 

·  Medical associations 

 · Foundations

 

Associate
Membership:
  
 

 ·  Federal,State, Local  Government Agencies
 

 ·  Corporations interested in viral hepatitis prevention, education and care 
 
 
Join NVHR Now!

 

 

 


Not a member of an organization that is eligible for membership?

 

Join Our Mailing List 

 

Save the Date: Rally in DC!


May 19, 2010, World Hepatitis Day: NVHR is sponsoring a Rally at the Capitol to mark the day. We need YOU to come to DC and let policy makers hear our mighty voice! Mark your calendars and stay tuned for more information.

 

 

Call to Action:  

 Ask Your Representative to Co-sponsor HR 3974

 

The Viral Hepatitis and Liver Cancer Prevention Bill (HR3974) now has 27 co-sponsors in Congress. We are aiming for 100 co-sponsors by World Hepatitis Day and we need your help! To find out if your representative has signed on, visit the Library of Congress, www.thomas.gov.  Enter HR 3974 in the search box and then click on sponsors.   If your representative has not signed on as a cosponsor, make a call!  The  NVHR Call to Action will provide you with important information about how to contact your representative.  The bill has not yet been introduced in the Senate.

 

Volunteers Needed for NVHR Membership Committee


The NVHR Steering Committee is making two-way communication with our members a top priority in 2010. We will be hosting quarterly conference calls as one way to attain that objective. At this time we are recruiting members to participate in a committee to help us plan the calls and identify other ways to have useful exchanges with and between our members.  Michael Ninburg will chair the membership committee and we are looking for NVHR members to join the committee. If you are interested in participating in the membership please email Mimi Schott, with you
r name, organization name and short statement of interest . We may not be able to invite all who are interested to join, as we are committed to having equal representation from hepatitis B and hepatitis C focused organizations.

 

 

New Tip Sheet from NVHR - Planning and Implementing Focus Groups

 

NVHR produces a series of tip sheets on a variety of topics to support the increased capacity and sustainability of non-profit member organizations. Our new tip sheet provides a clear outline about why, when and how to plan and conduct a successful focus group. Focus groups might help you to plan, improve, market and evaluate your programs and services.

 

Have You Read the IOM Report on Viral Hepatitis?


On January 11, the Institute of Medicine (IOM) released their report Viral Hepatitis and Liver Cancer: a National Strategy for Prevention and Control of Hepatitis B and C. By pointing out the lack of a federal response to viral hepatitis, the IOM report validates the work that community based organizations are doing with scarce resources. The report discusses many the gaps in services, giving useful evidence that there is much work to be done. The IOM report provides us with a significant tool to advocate for improved viral hepatitis programs at the local, state and federal level. You may download a copy of the report from the NVHR website.

 

Slides from the NVHR January 12 IOM webinar are posted here.

 

NVHR logo black and red

 NVHR Newsletter - 2009, the Year in Review

December 2009

_______________
NVHR wishes you a Happy New Year!

 

Steering Committee

Lorren Sandt, Chair

Jeff Caballero, Vice-Chair

Joan Block, Secretary

Dennis Simon, Treasurer

Bruce Burkett

Ryan Clary

Andrew Muir, MD

Michael Ninburg

Daniel Raymond

Chris Taylor

Deborah Wexler, MD

 

Staff

Martha Saly, Director

Mimi Schott, Admin Support

Rose Hessmiller,  Webmaster

 

 

Quick Links...

 

 

Our Website

 

 

Who Should Join NVHR?

Any organization committed to viral hepatitis prevention, care, advocacy, and education

 

Voting Members

 

·    Community-based organizations

 

 ·

· Clinics and health care agencies

·  Medical associations 

· Foundations 

  

Associate Members 

· Federal, State, Local  Government Agencies

 

·   Corporations interested in viral hepatitis prevention, education and care

 

 

Join NVHR Now! 

 

 

The Viral Hepatitis and Liver Cancer Prevention Act

   (HR 3974)  

 

On October 29, 2009, a bi-partisan group of representatives introduced a bill that combined separate hepatitis B and hepatitis C bills that were introduced in previous Congresses.  NVHR was instrumental in bringing together the advocates for each of the bills and worked with Congressmen Mike Honda (D-CA), Charles Dent (R-PA), William Cassidy (R-LA), Edolphus Towns (D-NY). HR3974 amends the Public Health Service Act to direct the Secretary of Health and Human Services to establish, promote, and support a comprehensive prevention, education, research, and medical management referral program for viral hepatitis infection. NVHR is working toward enlisting 100 cosponsors for HR 3974 by the first 100 days of 2010! We need advocates' help to make this happen. Read NVHR's call to action and call your representative today!  

 

Institute of Medicine Study of Viral Hepatitis 

 

 Coming Soon...

 

In 2008, NVHR in partnership with the Division of Viral Hepatitis and the Division of Cancer Prevention and Control of the Centers for Disease Control, the Department of Health and Human Services Office of Minority Health and the Department of Veterans Affairs, contracted with the Institute of Medicine of the National Academies (IOM) to study and report on the status of viral hepatitis in the United States. The charge to the IOM was to determine ways to reduce new hepatitis B and hepatitis C infections and the morbidity and mortality related to chronic viral hepatitis. The committee assessed current prevention and control efforts and identified priorities for further research, policy and action. The much anticipated IOM report will be made public on January 11, 2009, following briefings to the sponsors and members of the House and Senate! Watch for NVHR's announcement of the link the report and our webinar designed to introduce the report findings and provide tips on how to use the report for your advocacy efforts.

Congressman Hank Johnson (D, GA) Discloses Hepatitis C Status

 

Congressman Hank Johnson has been working with NVHR to learn about how he can support our advocacy on behalf of people with hepatitis B and C. What makes Congressman Johnson different than other supportive Representatives on Capitol Hill? This month, Congressman Johnson disclosed that he is being treated for hepatitis C at Walter Reed Medical Center. NVHR wishes Congressman Johnson well in his final months of treatment and we look forward to working with him to shine light on viral hepatitis and to show that viral hepatitis affects those in all walks of life. Read more about Congressman Johnson's disclosure here.

 

NVHR Visited Capitol Hill in 2009 - a Lot!

 

Visits to policy makers by NVHR staff and members were to numerous to account here. Some of these visits included: AASLD Hill Day, March 2009; World Hepatitis Day Congressional Briefing, May 19, 2009; Hepatitis B and C Congressional Testing Event (Cosponsored by AAPCHO, Chinese American Medical Society, Hepatitis B Foundation), July 2009; and the Congressional Briefing, September 2009. The topics covered during our meetings included increasing appropriations for the Division of Viral Hepatitis, supporting health care reform that includes access to care for people with viral hepatitis, removing the federal ban on syringe exchange program funding, and supporting viral hepatitis legislation. We saw some positive changes, and definitely feel we made an impact in terms of awareness of hepatitis B and hepatitis C among policy makers. We look forward to continuing these efforts in 2009, armed with the IOM report to support our advocacy efforts.